Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Opinion in Oncology|September 9, 2024
Endocrine therapy for early breast cancer in the era of oral selective estrogen receptor degraders: challenges and future perspectivesLiliana Ascione, Grazia Castellano, Giuseppe Curigliano, et al.
Expert Opinion on Investigational Drugs|September 27, 2021
Investigational immunomodulatory drugs for enhancement of triple negative breast cancer (TNBC) immunotherapy: early phase developmentPaolo Tarantino, Gabriele Antonarelli, Liliana Ascione, et al.
Cancers|July 2, 2021
Antibody-Drug Conjugates for the Treatment of Breast CancerChiara Corti, Federica Giugliano, Eleonora Nicolò, et al.
Journal of Personalized Medicine|December 29, 2022
PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-NegativeLiliana Ascione, Paola Zagami, Eleonora Nicolò, et al.
The Oncologist|September 4, 2023
Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' TargetabilityLiliana Ascione, Edoardo Crimini, Dario Trapani, et al.
Investigational New Drugs|May 25, 2022
The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046Matteo Repetto, Edoardo Crimini, Liliana Ascione, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 3, 2024
Unlocking the Potential: Biomarkers of Response to Antibody-Drug ConjugatesLiliana Ascione, Lorenzo Guidi, Ajay Prakash, et al.
Clinical Medicine Insights. Oncology|June 19, 2024
Use of Antibody-Drug Conjugates in the Early Setting of Breast CancerChrysanthi Koukoutzeli, Dario Trapani, Liliana Ascione, et al.
Therapeutic Advances in Medical Oncology|January 6, 2025
Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapyDavide Izzo, Liliana Ascione, Lorenzo Guidi, et al.
Cancer Treatment Reviews|April 25, 2022
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectivesEleonora Nicolò, Federica Giugliano, Liliana Ascione, et al.
Pageof 3